ZELBORAF (Genentech, Inc.)
Welcome to the PulseAid listing for the ZELBORAF drug offered from Genentech, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | Vemurafenib |
| SUBSTANCE NAME: | VEMURAFENIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-08-17 |
| END MARKETING DATE: | 0000-00-00 |
ZELBORAF HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZELBORAF from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 240(mg/1) |
| START MARKETING DATE: | 2011-08-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-090_12027f5f-f87f-4551-9ca0-1978bfbd1494 |
| PRODUCT NDC: | 50242-090 |
| APPLICATION NUMBER: | NDA202429 |
Other VEMURAFENIB Pharmaceutical Manufacturers / Labelers:
